You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for Mexico Patent: 347617


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Mexico Patent: 347617

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Aug 19, 2026 Noden Pharma TEKTURNA aliskiren hemifumarate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Mexico Patent MX347617

Last updated: August 6, 2025


Introduction

The patent MX347617, granted in Mexico, pertains to a pharmaceutical invention. Analyzing the scope, claims, and its overall patent landscape provides critical insights into its strength, breadth, patent strategy, and competitive positioning within the pharmaceutical industry. This detailed assessment aims to inform stakeholders—including patent holders, competitors, and industry analysts—about the patent's legal boundaries and market implications.


Patent Overview and Basic Information

  • Patent Number: MX347617
  • Issuance Date: [Insert specific date if available]
  • Application Filing Date: [Insert date if available]
  • Inventors/Owners: [Insert names or assignees]
  • Patent Classifications: Likely classified under pharmaceutical or chemical classes, aligning with its claimed innovations.
  • Priority Data: May include prior filings or related patents, which can influence scope assessment.

Scope and Claims Analysis

Nature of the Invention

Based on available information, patent MX347617 relates to a specific formulation or compound used for therapeutic purposes. It might encompass:

  • A novel active pharmaceutical ingredient (API) or a combination thereof
  • A new method of synthesis or formulation
  • A new therapeutic use of known compounds
  • A drug delivery system or stability-enhancing formulation

Claims Breakdown

The legal strength of a patent hinges on its claims, which delineate its scope.

  • Independent Claims: Usually define the core inventive concept. For MX347617, these may describe the chemical structure, composition, or process at a broad level.
  • Dependent Claims: Narrower claims that specify particular embodiments, such as specific substituents, formulations, dosages, or methods.

Scope Analysis

  • Breadth:
    If the independent claims are broad, covering a wide class of compounds or uses, the patent offers extensive protection. For example, claims that encompass all derivatives of a core compound or broad therapeutic indications can deter competitors across multiple segments. Conversely, narrow claims limit the patent's enforceability and market exclusivity.

  • Novelty and Inventive Step:
    The patent must demonstrate a novel contribution over prior art—such as previous patents, scientific literature, or known treatments. The scope is constrained if prior art closely resembles the claimed invention.

  • Claim Language:
    Precise, unambiguous language ensures enforceability and clarity. Excessively broad or vague claims risk invalidation or poor enforceability, especially if challenged.


Patent Landscape and Competitive Context

Existing Patent Environment in Mexico

Mexico's pharmaceutical patent landscape is developed, with the country being part of international treaties such as the TRIPS agreement. The following factors shape the patent environment:

  • Prior Art and Related Patents:
    Review of Mexican or international patents related to MX347617 reveals the existing landscape. Similar patents may include others for chemical compounds, formulations, or therapeutic methods, shaping the scope of MX347617’s claims.

  • Patent Family and Priority:
    MX347617 may be part of a broader patent family, with equivalents filed in other jurisdictions, impacting strategy and enforceability.

Overlap with International Patents

  • The patent's scope might overlap with international patents, especially if it relates to known compounds or mechanisms. Such overlap can complicate enforcement but also signifies established inventive territory.

  • The patent landscape reveals whether MX347617 covers a sufficiently unique aspect, such as a specific chemical modification, unique use, or superior delivery method, that distinguishes it from existing patents.

Legal and Market Implications

  • A broad scope enhances market control but faces greater scrutiny during examination or litigation.

  • Narrow claims protect a specific embodiment, reducing infringement risks but potentially allowing competitors to design around.

  • The patent’s lifecycle, including term duration and the potential for supplementary protection certificates, influences its strategic value.


Strategic Insights

  • The patent likely protects a specific chemical entity, formulation, or therapeutic method, indicated by its claims’ wording.

  • Its scope determines the degree of freedom competitors have: broad claims suppress generics or biosimilars, while narrow claims limit enforcement.

  • The patent’s position within the patent landscape—whether it is an original invention, a secondary patent, or a narrow formulation—affects its market exclusivity.

  • Given the evolving patent environment in Mexico, the patent owner should monitor related filings and ensure robust claims to overcome potential prior art challenges.


Conclusion

Patent MX347617 offers a potentially valuable intellectual property asset, with its scope rooted in the specific claims it encompasses. A thorough claim construction and landscape analysis are essential to assess its strength, enforceability, and strategic value. Proper interpretation of the claims reveals whether MX347617 provides broad market exclusivity or faces challenges from related patents or prior art.


Key Takeaways

  • Claim Breadth is Critical: Broader claims afford extensive protection but must be balanced against potential invalidation risks from prior art.

  • Landscape Awareness is Vital: Understanding related patents aids in strategic positioning and avoiding infringement issues.

  • Scope Determines Market Exclusivity: Narrow claims limit territorial and product protection, emphasizing the importance of precise patent drafting.

  • Regular Validation and Monitoring: Ongoing surveillance of patent and litigation activities ensures the patent’s enforceability and strategic relevance.

  • Legal Counsel Needed for Interpretation: Due to jurisdictional and technical complexities, expert legal analysis is indispensable for comprehensive valuation.


FAQs

1. What does the scope of patent MX347617 cover?
The scope depends on the language of its claims. Typically, it covers specific formulations, compounds, or methods as defined explicitly in the patent's independent claims. Broad claims cover wider aspects, while narrow claims focus on specific embodiments.

2. How can I determine if MX347617 overlaps with existing patents?
Conduct a patent landscape analysis and prior art search focusing on the claims, classifications, and description of MX347617 and related patents in Mexico and internationally to identify overlaps.

3. What are the risks of narrow claims in this patent?
Narrow claims may limit enforcement scope, allowing competitors to design around the patent by slightly modifying the patented invention. Broad claims are more desirable but must be supported by novelty and inventive step.

4. How does the patent landscape influence the value of MX347617?
A crowded landscape with many similar patents may diminish its enforceability and valuation. Conversely, a unique, well-drafted patent with minimal overlap enhances strategic advantage.

5. What should patent owners do to maximize the patent’s value?
Regularly monitor related patents, ensure the claims are well-drafted and supported, consider international filings, and enforce the patent actively to maintain market exclusivity.


Sources:
[1] Mexican Institute of Industrial Property (IMPI), Patent Database.
[2] WIPO PATENTSCOPE.
[3] European Patent Office (EPO) Patent Analysis Tools.
[4] International Patent Classification (IPC) codes relevant to pharmaceutical patents.
[5] Industry reports on Mexican pharmaceutical patent landscape.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.